2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Keloids: new trials by email Literature Review of Keloids trials Research Report on Keloids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sorafenib for Patients With Extensive Keloids Sorafenib - Keloids | Phase 2 | Terminated | Tirgan, Michael H., M.D. | 60 | 2013-03-01 | 2016-10-18 |
| Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence QAX576, QAX576 placebo - Keloids | Phase 2 | Terminated | Novartis Pharmaceuticals | 3 | 2009-06-01 | 2020-12-19 |
Keloid (2) · Recurrence (1)
Cicatrix (2) · Collagen Diseases (2) · Connective Tissue Diseases (2) · Fibrosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin and Connective Tissue Diseases (2) · Disease Attributes (1)
Sorafenib (1)
Novartis Pharmaceuticals (1) · Tirgan, Michael H., M.D. (1)
United States (2)